Additionally, FXR prevents the progression of kidney disease in mouse models of type 1 and type 2 diabetes mellitus, and diet induced obesity and insulin resistance by regulating the metabolism of glucose and lipid25, 33, 34, 35, 36. This evidence concerns the gene NR1H4 and obesity disorder.